INTRODUCTION: Lymphomas are a heterogeneous group of immune-cell malignancies. Immunology-related conditions are among the few factors for which consistent evidence exists relating them to lymphoma risk. MATERIALS AND METHODS: We used the data from the European case-control study Epilymph on 2,362 lymphoma cases and 2,458 controls to investigate associations between a medical history of infectious and non-infectious diseases with overall and subentity-specific lymphoma risk. RESULTS: As key results, we observed an increased odds ratio (OR) for self-reported infections with hepatitis B virus (HBV, OR = 1.91, 95% CL = 1.24-2.94) and a null result for rheumatoid arthritis. Additionally, we found an increased OR for infectious mononucleosis (OR = 1.68, 95% CL = 1.14-2.48), an inverse association to frequency of sickness in childhood (OR = 0.68, 95% CL = 0.55-0.84), and-as casual finding-an increased OR with acetaminophen intake (OR = 2.29, 95% CL = 1.49-3.51). CONCLUSION: Our results are consistent with the current knowledge about the association with mononucleosis as indicator of Epstein-Barr-virus infection, suggest serological study of the association to HBV infection and do not support the view of a positive association between rheumatoid arthritis and lymphoma risk.
INTRODUCTION:Lymphomas are a heterogeneous group of immune-cell malignancies. Immunology-related conditions are among the few factors for which consistent evidence exists relating them to lymphoma risk. MATERIALS AND METHODS: We used the data from the European case-control study Epilymph on 2,362 lymphoma cases and 2,458 controls to investigate associations between a medical history of infectious and non-infectious diseases with overall and subentity-specific lymphoma risk. RESULTS: As key results, we observed an increased odds ratio (OR) for self-reported infections with hepatitis B virus (HBV, OR = 1.91, 95% CL = 1.24-2.94) and a null result for rheumatoid arthritis. Additionally, we found an increased OR for infectious mononucleosis (OR = 1.68, 95% CL = 1.14-2.48), an inverse association to frequency of sickness in childhood (OR = 0.68, 95% CL = 0.55-0.84), and-as casual finding-an increased OR with acetaminophen intake (OR = 2.29, 95% CL = 1.49-3.51). CONCLUSION: Our results are consistent with the current knowledge about the association with mononucleosis as indicator of Epstein-Barr-virus infection, suggest serological study of the association to HBV infection and do not support the view of a positive association between rheumatoid arthritis and lymphoma risk.
Authors: Karin Ekström Smedby; Henrik Hjalgrim; Johan Askling; Ellen T Chang; Henrik Gregersen; Anna Porwit-MacDonald; Christer Sundström; Måns Akerman; Mads Melbye; Bengt Glimelius; Hans-Olov Adami Journal: J Natl Cancer Inst Date: 2006-01-04 Impact factor: 13.506
Authors: M Kuniyoshi; M Nakamuta; H Sakai; M Enjoji; N Kinukawa; K Kotoh; M Fukutomi; M Yokota; H Nishi; H Iwamoto; N Uike; J Nishimura; S Inaba; Y Maeda; H Nawata; K Muta Journal: J Gastroenterol Hepatol Date: 2001-02 Impact factor: 4.029
Authors: H L Howe; P A Wingo; M J Thun; L A Ries; H M Rosenberg; E G Feigal; B K Edwards Journal: J Natl Cancer Inst Date: 2001-06-06 Impact factor: 13.506
Authors: Joan Fortuny; Yolanda Benavente; Ramon Bosch; Mercedes García-Villanueva; Alberto Fernández de Sevilla; Sílvia de Sanjosé Journal: Eur J Cancer Date: 2005-08 Impact factor: 9.162
Authors: Lesley A Anderson; Ruth Pfeiffer; Joan L Warren; Ola Landgren; Shahinaz Gadalla; Sonja I Berndt; Winnie Ricker; Ruth Parsons; William Wheeler; Eric A Engels Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-10-28 Impact factor: 4.254
Authors: Herve Besson; Paul Brennan; Nikolaus Becker; Alexandra Nieters; Silvia De Sanjosé; Rebeca Font; Marc Maynadié; Lenka Foretova; Pierluigi L Cocco; Anthony Staines; Martine Vornanen; Paolo Boffetta Journal: Int J Cancer Date: 2006-08-15 Impact factor: 7.396
Authors: Nikolaus Becker; Michael O Falster; Claire M Vajdic; Silvia de Sanjose; Otoniel Martínez-Maza; Paige M Bracci; Mads Melbye; Karin Ekström Smedby; Eric A Engels; Jennifer Turner; Paolo Vineis; Adele Seniori Costantini; Elizabeth A Holly; John J Spinelli; Carlo La Vecchia; Tongzhang Zheng; Brian C-H Chiu; Maurizio Montella; Pierluigi Cocco; Marc Maynadié; Lenka Foretova; Anthony Staines; Paul Brennan; Scott Davis; Richard Severson; James R Cerhan; Elizabeth C Breen; Brenda Birmann; Wendy Cozen; Andrew E Grulich; Robert Newton Journal: Int J Cancer Date: 2012-08-12 Impact factor: 7.396
Authors: Nikolaus Becker; Paul Schnitzler; Paolo Boffetta; Paul Brennan; Lenka Foretova; Marc Maynadié; Alexandra Nieters; Anthony Staines; Yolanda Benavente; Pierluigi Cocco; Silvia de Sanjose Journal: J Cancer Res Clin Oncol Date: 2012-07-06 Impact factor: 4.553
Authors: Niquelle Brown Wadé; Cindy M Chang; David Conti; Joshua Millstein; Christine Skibola; Alexandra Nieters; Sophia S Wang; Silvia De Sanjose; Eleanor Kane; John J Spinelli; Paige Bracci; Yawei Zhang; Susan Slager; Jun Wang; Henrik Hjalgrim; Karin Ekstrom Smedby; Elizabeth E Brown; Ruth F Jarrett; Wendy Cozen Journal: Cancer Causes Control Date: 2020-03-02 Impact factor: 2.532